Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study	Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder	Recruiting	Not stated	2025-07-30		NCT07093294

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First People's Hospital of Chenzhou	9
The Central Hospital of Shaoyang City	2
The First Affiliated Hospital of University of South China	21
The First People's Hospital of Changde City	10
The Third Xiangya Hospital of Central South University	75

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The Third Xiangya Hospital of Central South University	Changsha	China	11